Literature DB >> 10650291

Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database.

E D Peterson1, A J Lansky, K J Anstrom, L H Muhlbaier, J J Popma, L F Satler, M J Lanzilotta.   

Abstract

BACKGROUND: Although multiple new coronary interventional devices have been approved for marketing in the United States, use of these technologies in general clinical practice and their associated outcomes have not been reported. METHODS AND
RESULTS: Using the National Cardiovascular Network's Coronary Interventional Database, we examined temporal trends in the use and outcomes of coronary stents, lasers, directional atherectomy, and rotational atherectomy devices at 12 US hospitals between January 1994 and December 1997 (n = 76,904). Over this period, the percentage of cases involving coronary stents rose more than 12-fold (from 5.4% in 1994 to 69.0% in 1997). In contrast, use of atherectomy-type devices declined significantly. Device selection was strongly influenced by the patient's coronary anatomy and procedural indication, but less by age, sex, or race. Device use also varied significantly among individual centers (4-fold variation among sites in stent use and 6-fold variation in atherectomy use) even after adjusting for patient characteristics. Although overall mortality rates were unchanged during this 4-year period, procedural success rates have improved and complication rates have declined significantly. Lengths of postprocedure hospital stay also fell significantly for all patients undergoing coronary intervention in this time period.
CONCLUSIONS: Percutaneous interventional strategies are rapidly changing with the explosive growth of coronary stent use and the decline in use of atherectomy devices. Patient outcomes, including complication rates and postprocedure lengths of stay, have also improved as the new interventional strategies have been refined in clinical practice.

Entities:  

Mesh:

Year:  2000        PMID: 10650291     DOI: 10.1067/mhj.2000.103848

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Differences in level of care at the end of life according to race.

Authors:  Rebecca W Johnson; L Kristin Newby; Christopher B Granger; Wendy A Cook; Eric D Peterson; Melvin Echols; Wanda Bride; Bradi B Granger
Journal:  Am J Crit Care       Date:  2010-07       Impact factor: 2.228

2.  Heparin in interventional radiology: a therapy in evolution.

Authors:  Stuart B Resnick; Stephanie H Resnick; Joshua L Weintraub; Nishita Kothary
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

3.  Biomedical and psychosocial predictors of anginal frequency in patients following angioplasty with and without coronary stenting.

Authors:  Brian C Sirois; Samuel F Sears; Barry Bertolet
Journal:  J Behav Med       Date:  2003-12

4.  Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis.

Authors:  Samer Al Said; Samer Alabed; Klaus Kaier; Audrey R Tan; Christoph Bode; Joerg J Meerpohl; Daniel Duerschmied
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

5.  Insights into temporal patterns of hospital patient safety from routinely collected electronic data.

Authors:  Blanca Gallego; Farah Magrabi; Oscar Perez Concha; Ying Wang; Enrico Coiera
Journal:  Health Inf Sci Syst       Date:  2015-02-24

6.  Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovation.

Authors:  Aaron S Kesselheim; Shuai Xu; Jerry Avorn
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

7.  Reappraisal Value of a Modified Rotational Atherectomy Technique in Contemporary Coronary Angioplasty Era.

Authors:  Haojian Dong; Daisuke Hachinohe; Zhiqiang Nie; Yoshifumi Kashima; Jianfang Luo; Takuya Haraguchi; Hidemasa Shitan; Tomohiko Watanabe; Yutaka Tadano; Umihiko Kaneko; Takuro Sugie; Ken Kobayashi; Daitaro Kanno; Morio Enomoto; Katsuhiko Sato; Tsutomu Fujita
Journal:  J Interv Cardiol       Date:  2020-01-23       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.